Avacopan for Patients with ANCA-associated Vasculitis

被引：0
|
作者：
Rauen, Thomas [1 ]
Kraemer, Stefan [1 ]
Floege, Juergen [1 ]
机构：
[1] Univ Klinikum RWTH Aachen, Med Klin 2, Klin Nieren & Hochdruckkrankheiten Rheumatol, Aachen, Germany
来源：
NEPHROLOGIE | 2022年 / 17卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Springer, Jason
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (02) : 223 - 232
  • [32] Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
    Cortazar, Frank B.
    Niles, John L.
    Jayne, David R. W.
    Merkel, Peter A.
    Bruchfeld, Annette
    Yue, Huibin
    Schall, Thomas J.
    Bekker, Pirow
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 860 - 870
  • [33] EFFICACY AND SAFETY OF AVACOPAN IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS RECEIVING RITUXIMAB IN THE ADVOCATE TRIAL
    Geetha, D.
    Dua, A.
    Yue, H.
    Salvarani, C.
    Jayne, D.
    Merkel, P. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 338 - 339
  • [34] In ANCA-associated vasculitis, avacopan was superior to prednisone taper for sustained remission
    Khan, Mubeen M.
    Molony, Donald A.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (07) : JC79 - JC79
  • [35] Is it possible to use avacopan alone in the induction of remission in ANCA-associated vasculitis?
    Kubota, Soichiro
    Hanai, Shunichiro
    Tanaka-Mabuchi, Nakako
    Ito, Ryosuke
    Nakagomi, Daiki
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (03)
  • [36] COST-UTILITY ANALYSIS OF AVACOPAN FOR THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS (AAV) PATIENTS IN THE UK
    Serna, Ramirez de Arellano A.
    Berdunov, V
    Baxter, G.
    VALUE IN HEALTH, 2022, 25 (12) : S130 - S130
  • [37] Avacopan for ANCA-Associated Vasculitis in Ireland: A Report on All Patients Who Received Avacopan in the Irish Health Care System
    Nic an Riogh, Eithne Muireann
    Cummiskey, Andy Gerard
    Stoneman, Sinead
    Clarkson, Michael
    Moran, Sarah Margaret
    Magee, Ciara N.
    McAnallen, Susan Marie
    Little, Mark Alan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [38] Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1366 - 1367
  • [39] Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
    van Leeuwen, Jolijn R.
    Quartuccio, Luca
    Draibe, Juliana Bordignon
    Gunnarson, Iva
    Sprangers, Ben
    Teng, Y. K. Onno
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19
  • [40] Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan
    Alvarez, Luis
    Kambham, Neeraja
    Su, Robert
    JOURNAL OF NEPHROLOGY, 2023, 36 (08) : 2365 - 2370
12345